Qkine
Cambridge
About Qkine
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-up challenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2022)
- Website: qkine.com
- Phone: [email protected]
Industries & Categories
Alternative Protein, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/qkine-21148 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.